COUP-TFII orchestrates venous and lymphatic endothelial identity by homo- or hetero-dimerisation with PROX1

Journal of Cell Science

Volumn 126, Issue 5, 2013, Pages 1164-1175

  Aranguren, Xabier L ^a   Beerens, Manu ^a   Coppiello, Giulia ^a   Wiese, Cornelia ^b   Vandersmissen, Ine ^a   Nigro, Antonio Lo ^c   Verfaillie, Catherine M ^c   Gessler, Manfred ^b   Luttun, Aernout ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

COUP TFII; Endothelial specification; Notch signalling; Prox1

Indexed keywords

CHICKEN OVALBUMIN UPSTREAM PROMOTER TRANSCRIPION FACTOR II; HETERODIMER; HOMODIMER; NOTCH RECEPTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PROX1; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CELL FATE; CONTROLLED STUDY; DIMERIZATION; ENDOTHELIUM CELL; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE TARGETING; HUMAN; HUMAN CELL; LYMPH VESSEL ENDOTHELIUM; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN DNA BINDING; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM;

BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BLOTTING, WESTERN; CELL CYCLE PROTEINS; CELL LINE; CELLS, CULTURED; CHROMATIN IMMUNOPRECIPITATION; COUP TRANSCRIPTION FACTOR II; ENDOTHELIUM, VASCULAR; HOMEODOMAIN PROTEINS; HUMANS; LYMPHATIC VESSELS; PROTEIN MULTIMERIZATION; REAL-TIME POLYMERASE CHAIN REACTION; REPRESSOR PROTEINS; TUMOR SUPPRESSOR PROTEINS; VEINS;

EID: 84877901574     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.116293     Document Type: Article

References (42)

1. Aird, W. C. (2007a). Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms. Circ. Res. 100, 158-173.
2. Aird, W. C. (2007b). Phenotypic heterogeneity of the endothelium: II. Representative vascular beds. Circ. Res. 100, 174-190.
3. Aranguren, X. L., Luttun, A., Clavel, C., Moreno, C., Abizanda, G., Barajas, M. A., Pelacho, B., Uriz, M., Aran~ a, M., Echavarri, A. et al. (2007). In vitro and in vivo arterial differentiation of human multipotent adult progenitor cells. Blood 109, 2634-2642.
4. Aranguren, X. L., Beerens, M., Vandevelde, W., Dewerchin, M., Carmeliet, P. and Luttun, A. (2011). Transcription factor COUP-TFII is indispensable for venous and lymphatic development in zebrafish and Xenopus laevis. Biochem. Biophys. Res. Commun. 410, 121-126.
5. Charest-Marcotte, A., Dufour, C. R., Wilson, B. J., Tremblay, A. M., Eichner, L. J., Arlow, D. H., Mootha, V. K. and Giguère, V. (2010). The homeobox protein Prox1 is a negative modulator of ERRalpha/PGC-1alpha bioenergetic functions. Genes Dev. 24, 537-542.
6. Chen, X., Qin, J., Cheng, C. M., Tsai, M. J. and Tsai, S. Y. (2012). COUP-TFII is a major regulator of cell cycle and Notch signaling pathways. Mol. Endocrinol. 26, 1268-1277.
7. Consiglio, A., Gritti, A., Dolcetta, D., Follenzi, A., Bordignon, C., Gage, F. H., Vescovi, A. L. and Naldini, L. (2004). Robust in vivo gene transfer into adult mammalian neural stem cells by lentiviral vectors. Proc. Natl. Acad. Sci. USA 101, 14835-14840.
8. Cooney, A. J., Tsai, S. Y., O'Malley, B. W. and Tsai, M. J. (1992). Chicken ovalbumin upstream promoter transcription factor (COUP-TF) dimers bind to different GGTCA response elements, allowing COUP-TF to repress hormonal induction of the vitamin D3, thyroid hormone, and retinoic acid receptors. Mol. Cell. Biol. 12, 4153-4163.
9. Corada, M., Nyqvist, D., Orsenigo, F., Caprini, A., Giampietro, C., Taketo, M. M., Iruela-Arispe, M. L., Adams, R. H. and Dejana, E. (2010). The Wnt/beta-catenin pathway modulates vascular remodeling and specification by upregulating Dll4/Notch signaling. Dev. Cell 18, 938-949.
10. Fischer, A., Schumacher, N., Maier, M., Sendtner, M. and Gessler, M. (2004). The Notch target genes Hey1 and Hey2 are required for embryonic vascular development. Genes Dev. 18, 901-911.
11. Gessler, M., Knobeloch, K. P., Helisch, A., Amann, K., Schumacher, N., Rohde, E., Fischer, A. and Leimeister, C. (2002). Mouse gridlock: no aortic coarctation or deficiency, but fatal cardiac defects in Hey2 -/- mice. Curr. Biol. 12, 1601-1604.
12. Geudens, I., Herpers, R., Hermans, K., Segura, I., Ruiz de Almodovar, C., Bussmann, J., De Smet, F., Vandevelde, W., Hogan, B. M., Siekmann, A. et al. (2010). Role of delta-like-4/Notch in the formation and wiring of the lymphatic network in zebrafish. Arterioscler. Thromb. Vasc. Biol. 30, 1695-1702.
13. Hayashi, H. and Kume, T. (2008). Foxc transcription factors directly regulate Dll4 and Hey2 expression by interacting with the VEGF-Notch signaling pathways in endothelial cells. PLoS ONE 3, e2401.
14. Hendrickx, B., Verdonck, K., Van den Berge, S., Dickens, S., Eriksson, E., Vranckx, J. J. and Luttun, A. (2010). Integration of blood outgrowth endothelial cells in dermal fibroblast sheets promotes full thickness wound healing. Stem Cells 28, 1165-1177.
15. Kang, J., Yoo, J., Lee, S., Tang, W., Aguilar, B., Ramu, S., Choi, I., Otu, H. H., Shin, J. W., Dotto, G. P. et al. (2010). An exquisite cross-control mechanism among endothelial cell fate regulators directs the plasticity and heterogeneity of lymphatic endothelial cells. Blood 116, 140-150.
16. Krebs, L. T., Shutter, J. R., Tanigaki, K., Honjo, T., Stark, K. L. and Gridley, T. (2004). Haploinsufficient lethality and formation of arteriovenous malformations in Notch pathway mutants. Genes Dev. 18, 2469-2473.
17. Kruse, S. W., Suino-Powell, K., Zhou, X. E., Kretschman, J. E., Reynolds, R., Vonrhein, C., Xu, Y., Wang, L., Tsai, S. Y., Tsai, M. J. et al. (2008). Identification of COUP-TFII orphan nuclear receptor as a retinoic acid-activated receptor. PLoS Biol. 6, e227.
18. Larrive'e, B., Prahst, C., Gordon, E., del Toro, R., Mathivet, T., Duarte, A., Simons, M. and Eichmann, A. (2012). ALK1 signaling inhibits angiogenesis by cooperating with the Notch pathway. Dev. Cell 22, 489-500.
19. Lee, S., Kang, J., Yoo, J., Ganesan, S. K., Cook, S. C., Aguilar, B., Ramu, S., Lee, J. and Hong, Y. K. (2009). Prox1 physically and functionally interacts with COUPTFII to specify lymphatic endothelial cell fate. Blood 113, 1856-1859.
20. Li, L., Xie, X., Qin, J., Jeha, G. S., Saha, P. K., Yan, J., Haueter, C. M., Chan, L., Tsai, S. Y. and Tsai, M. J. (2009). The nuclear orphan receptor COUP-TFII plays an essential role in adipogenesis, glucose homeostasis, and energy metabolism. Cell Metab. 9, 77-87.
21. Lin, F. J., Chen, X., Qin, J., Hong, Y. K., Tsai, M. J. and Tsai, S. Y. (2010). Direct transcriptional regulation of neuropilin-2 by COUP-TFII modulates multiple steps in murine lymphatic vessel development. J. Clin. Invest. 120, 1694-1707.
22. Morikawa, M., Koinuma, D., Tsutsumi, S., Vasilaki, E., Kanki, Y., Heldin, C.-H., Aburatani, H. and Miyazono, K. (2011). ChIP-seq reveals cell type-specific binding patterns of BMP-specific Smads and a novel binding motif. Nucleic Acids Res. 39, 8712-8727.
23. Niessen, K., Zhang, G., Ridgway, J. B., Chen, H., Kolumam, G., Siebel, C. W. and Yan, M. (2011). The Notch1-Dll4 signaling pathway regulates mouse postnatal lymphatic development. Blood 118, 1989-1997.
24. Oliver, G. and Srinivasan, R. S. (2010). Endothelial cell plasticity: how to become and remain a lymphatic endothelial cell. Development 137, 363-372.
25. Pereira, F. A., Qiu, Y., Zhou, G., Tsai, M. J. and Tsai, S. Y. (1999). The orphan nuclear receptor COUP-TFII is required for angiogenesis and heart development. Genes Dev. 13, 1037-1049.
26. Pereira, F. A., Tsai, M. J. and Tsai, S. Y. (2000). COUP-TF orphan nuclear receptors in development and differentiation. Cell. Mol. Life Sci. 57, 1388-1398.
27. Sanalkumar, R., Dhanesh, S. B. and James, J. (2010). Non-canonical activation of Notch signaling/target genes in vertebrates. Cell. Mol. Life Sci. 67, 2957-2968.
28. Shawber, C. J. and Kitajewski, J. (2008). Arterial regulators taken up by lymphatics. Lymphat. Res. Biol. 6, 139-143.
29. Shawber, C. J., Funahashi, Y., Francisco, E., Vorontchikhina, M., Kitamura, Y., Stowell, S. A., Borisenko, V., Feirt, N., Podgrabinska, S., Shiraishi, K. et al. (2007). Notch alters VEGF responsiveness in human and murine endothelial cells by direct regulation of VEGFR-3 expression. J. Clin. Invest. 117, 3369-3382.
30. Shin, J. W., Min, M., Larrieu-Lahargue, F., Canron, X., Kunstfeld, R., Nguyen, L., Henderson, J. E., Bikfalvi, A., Detmar, M. and Hong, Y. K. (2006). Prox1 promotes lineage-specific expression of fibroblast growth factor (FGF) receptor-3 in lymphatic endothelium: a role for FGF signaling in lymphangiogenesis. Mol. Biol. Cell 17, 576-584.
31. Sörensen, I., Adams, R. H. and Gossler, A. (2009). DLL1-mediated Notch activation regulates endothelial identity in mouse fetal arteries. Blood 113, 5680-5688.
32. Srinivasan, R. S. and Oliver, G. (2011). Prox1 dosage controls the number of lymphatic endothelial cell progenitors and the formation of the lymphovenous valves. Genes Dev. 25, 2187-2197.
33. Srinivasan, R. S., Dillard, M. E., Lagutin, O. V., Lin, F. J., Tsai, S., Tsai, M. J., Samokhvalov, I. M. and Oliver, G. (2007). Lineage tracing demonstrates the venous origin of the mammalian lymphatic vasculature. Genes Dev. 21, 2422-2432.
34. Srinivasan, R. S., Geng, X., Yang, Y., Wang, Y., Mukatira, S., Studer, M., Porto, M. P., Lagutin, O. and Oliver, G. (2010). The nuclear hormone receptor Coup-TFII is required for the initiation and early maintenance of Prox1 expression in lymphatic endothelial cells. Genes Dev. 24, 696-707.
35. Swift, M. R. and Weinstein, B. M. (2009). Arterial-venous specification during development. Circ. Res. 104, 576-588.
36. Tammela, T., Zarkada, G., Nurmi, H., Jakobsson, L., Heinolainen, K., Tvorogov, D., Zheng, W., Franco, C. A., Murtomäki, A., Aranda, E. et al. (2011). VEGFR-3 1174 Journal of Cell Science 126 (5) controls tip to stalk conversion at vessel fusion sites by reinforcing Notch signalling. Nat. Cell Biol. 13, 1202-1213.
37. Timmerman, L. A., Grego-Bessa, J., Raya, A., Bertrán, E., Pérez-Pomares, J. M., Díez, J., Aranda, S., Palomo, S., McCormick, F., Izpisúa-Belmonte, J. C. et al. (2004). Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation. Genes Dev. 18, 99-115.
38. Tsai, S. Y. and Tsai, M. J. (1997). Chick ovalbumin upstream promoter-transcription factors (COUP-TFs): coming of age. Endocr. Rev. 18, 229-240.
39. Wang, H. U., Chen, Z. F. and Anderson, D. J. (1998). Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell 93, 741-753.
40. Yamazaki, T., Yoshimatsu, Y., Morishita, Y., Miyazono, K. and Watabe, T. (2009). COUP-TFII regulates the functions of Prox1 in lymphatic endothelial cells through direct interaction. Genes Cells 14, 425-434.
41. You, L. R., Lin, F. J., Lee, C. T., DeMayo, F. J., Tsai, M. J. and Tsai, S. Y. (2005). Suppression of Notch signalling by the COUP-TFII transcription factor regulates vein identity. Nature 435, 98-104.
42. Zheng, W., Tammela, T., Yamamoto, M., Anisimov, A., Holopainen, T., Kaijalainen, S., Karpanen, T., Lehti, K., Ylä-Herttuala, S. and Alitalo, K. (2011). Notch restricts lymphatic vessel sprouting induced by vascular endothelial growth factor. Blood 118, 1154-1162.